Diffuse Myocardial Fibrosis in Fontan Patients
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01929174|
Recruitment Status : Completed
First Posted : August 27, 2013
Last Update Posted : April 16, 2019
|Condition or disease|
|Congenital Heart Disease Single Ventricle Myocardial Fibrosis|
|Study Type :||Observational|
|Actual Enrollment :||18 participants|
|Official Title:||Heart Failure and Fibrosis in Adult Congenital Heart Patients With a Single Ventricle and Prior Fontan Operation.|
|Actual Study Start Date :||August 1, 2013|
|Actual Primary Completion Date :||May 1, 2016|
|Actual Study Completion Date :||March 1, 2019|
Patients undergoing catheterization for other reasons who have a normal biventricular heart.
Single ventricle Fontan
Patients with a single functional ventricle (excluding hypoplastic left heart syndrome) palliated with a "Fontan" type operation involving passive blood flow to the lungs.
- Myocardial fibrosis measured by the extracellular volume fraction [ Time Frame: 1 day of single observation ]All patients will have measurements of pressure and volume before and after IV fluid administration, as well as computation of their extracellular volume fraction.
Biospecimen Retention: Samples Without DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01929174
|United States, Oregon|
|Oregon Health and Science Univ.|
|Portland, Oregon, United States, 97239|
|Principal Investigator:||Craig Broberg||Oregon Health and Science University|